Development and validation of a pictorial nausea rating scale for children

Amy L Baxter1, Mehernoor F Watcha, William Valentine Baxter

  • 1Medical College of Georgia, Pediatric Emergency Medicine Associates, Atlanta, Georgia, USA. amy_baxter@PEMA-LLC.com

Pediatrics
|June 1, 2011
PubMed

Insights

A new pictorial scale, the Baxter Retching Faces (BARF) scale, effectively measures pediatric nausea intensity. This validated tool shows promise for improving nausea management in children.

Area of Science:

  • Pediatric Gastroenterology
  • Pain and Symptom Management
  • Psychometrics

Background:

  • Effective pediatric nausea assessment is limited by the absence of a widely adopted, validated tool.
  • Accurate measurement of nausea intensity is crucial for appropriate management in children.

Purpose of the Study:

  • To develop and validate a pictorial scale for assessing pediatric nausea severity.
  • To create a tool with incremental score levels representing increasing nausea intensity.

Main Methods:

  • The Baxter Retching Faces (BARF) scale, a 0-10 pictorial scale with 6 faces, was developed in three stages.
  • Validation involved emergency department and day surgery patients (ages 7-18), comparing BARF scores with visual analog scales (VAS) for nausea and pain, and the Faces Pain Scale-Revised (FPSR).
  • Paired t-tests and Spearman's rho correlations assessed scale validity and responsiveness to antiemetic treatment.

Main Results:

  • The BARF scale demonstrated strong convergent validity with VAS for nausea (Spearman's ρ = 0.93).
  • BARF and VAS nausea scores were significantly higher in patients needing antiemetics and decreased significantly post-treatment.
  • The scale showed discriminant validity, as scores did not significantly change in patients receiving only antiemetics.

Conclusions:

  • The BARF scale is a newly developed pictorial tool with initial evidence of construct validity for self-reported pediatric nausea severity.
  • The scale exhibits convergent and discriminant validity and can detect changes in nausea following treatment.
  • The BARF scale offers a promising, validated method for assessing pediatric nausea.
Abstract

Related Concept Videos

Assessment of the Gastrointestinal System II: Health Perception Pattern01:29

Assessment of the Gastrointestinal System II: Health Perception Pattern

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems related to...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through interaction...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...